Unlock instant, AI-driven research and patent intelligence for your innovation.

Enzymatic method for synthesizing the intermediate of Imitasvir

A synthetic method and lipase technology, applied in the field of medicine, can solve the problem of low selectivity

Active Publication Date: 2022-02-15
HEC PHARM CO LTD
View PDF10 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] In the prior art, WO2014019344 discloses the chemical synthesis route of emitasvir, which has certain limitations and low selectivity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Enzymatic method for synthesizing the intermediate of Imitasvir
  • Enzymatic method for synthesizing the intermediate of Imitasvir
  • Enzymatic method for synthesizing the intermediate of Imitasvir

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0077] Take 1 g of CALB lipase enzyme powder (obtained commercially) and add 90 mL of phosphate buffer (100 mM, pH 7.4) to dissolve to obtain an enzyme solution. 4 g of diester (compound of formula 5, wherein R is ethyl) was dissolved in methyl tert-butyl ether (MTBE), and the final volume was 10 mL of substrate solution. The 10 mL substrate solution was added into the enzyme solution to obtain an enzyme reaction system. Add condensing reflux to the enzyme reaction system (to reduce the loss of organic solvents), stir magnetically at 40°C for 18 hours, extract the reaction solution with dichloromethane after the conversion of the substrate is complete, and detect the reaction product by HPLC. The HPLC detection result shows that the monoester B is The reaction conversion rate is 98%, and the ee value reaches 95%.

Embodiment 2-6

[0079] Except changing the solvent in the enzyme reaction system, other conditions are all the same as in Example 1, and the HPLC detection results are shown in the following table 1:

[0080] Table 1: Effect of solvents on reactions

[0081]

[0082] As can be seen from the results in Table 1, when substrate concentration 40g / L, enzyme amount 10g / L, organic solvent consumption 10% (v / v), 40 ℃ reacted 18h, reacted with methyl tert-butyl ether (MTBE) When being an organic solvent, the conversion rate and ee value of the reaction are optimal, so the best solvent in the present invention is methyl tert-butyl ether (MTBE).

Embodiment 7-10

[0084] Except changing temperature of reaction, other conditions are all identical with embodiment 1, and HPLC detection result is shown in table 2 below:

[0085] Table 2: Effect of Temperature on Reaction

[0086]

[0087]

[0088] As can be seen from the results in Table 2, when the substrate concentration is 40g / L, the amount of enzyme is 10g / L, MTBE is an organic solvent (10%v / v), the reaction is 18h, and the conversion rate of the reaction is the highest when the reaction temperature is 40°C Excellent, so the optimum reaction temperature in the present invention is 40 ℃.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides the enzymatic synthesis method of the key intermediate (formula 6) of emitasvir, said method comprises utilizing lipase to carry out the catalytic reaction of substrate formula 5 to obtain the compound of formula 6: (wherein, R is C1- C6 alkyl).

Description

technical field [0001] The invention belongs to the field of medicines, and in particular relates to a synthesis method of an emitasvir intermediate. Background technique [0002] Hepatitis C virus, referred to as hepatitis C, hepatitis C, is a kind of viral hepatitis caused by hepatitis C virus (HCV) infection. According to the statistics of the World Health Organization, the global HCV infection rate is about 3%. It is estimated that about 180 million people are infected with HCV, and about 35,000 new cases of hepatitis C occur every year. Hepatitis C is a global epidemic, which can lead to chronic inflammation, necrosis and fibrosis of the liver, and some patients can develop liver cirrhosis and even hepatocellular carcinoma (HCC). [0003] DAA (direct-acting antiviral agents) small-molecule hepatitis C drugs refer to small-molecule drugs that directly fight against hepatitis C virus. The non-structural proteins NS3 / 4A, NS5B and NS5A of hepatitis C virus are the main ta...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12P7/24C12N9/20C07D403/14
CPCC12P7/24C12N9/20C12Y301/01003C07D403/14C07B2200/07
Inventor 李拓王小龙张慧叶燕全麦倩婷许亚韬屈代鑫王欢
Owner HEC PHARM CO LTD